CING
Price
$3.41
Change
+$0.03 (+0.89%)
Updated
Nov 19, 04:59 PM (EDT)
Capitalization
23.11M
Intraday BUY SELL Signals
CRBU
Price
$1.82
Change
-$0.05 (-2.67%)
Updated
Nov 19, 04:59 PM (EDT)
Capitalization
170.11M
116 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CING vs CRBU

Header iconCING vs CRBU Comparison
Open Charts CING vs CRBUBanner chart's image
Cingulate
Price$3.41
Change+$0.03 (+0.89%)
Volume$500
Capitalization23.11M
Caribou Biosciences
Price$1.82
Change-$0.05 (-2.67%)
Volume$14.53K
Capitalization170.11M
CING vs CRBU Comparison Chart in %
CING
Daily Signal:
Gain/Loss:
CRBU
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
CING vs. CRBU commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CING is a Hold and CRBU is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 20, 2025
Stock price -- (CING: $3.40 vs. CRBU: $1.82)
Brand notoriety: CING and CRBU are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CING: 46% vs. CRBU: 33%
Market capitalization -- CING: $23.11M vs. CRBU: $170.11M
CING [@Biotechnology] is valued at $23.11M. CRBU’s [@Biotechnology] market capitalization is $170.11M. The market cap for tickers in the [@Biotechnology] industry ranges from $106.82B to $0. The average market capitalization across the [@Biotechnology] industry is $2.15B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CING’s FA Score shows that 1 FA rating(s) are green whileCRBU’s FA Score has 1 green FA rating(s).

  • CING’s FA Score: 1 green, 4 red.
  • CRBU’s FA Score: 1 green, 4 red.
According to our system of comparison, both CING and CRBU are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CING’s TA Score shows that 3 TA indicator(s) are bullish while CRBU’s TA Score has 3 bullish TA indicator(s).

  • CING’s TA Score: 3 bullish, 6 bearish.
  • CRBU’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, both CING and CRBU are a bad buy in the short-term.

Price Growth

CING (@Biotechnology) experienced а -7.36% price change this week, while CRBU (@Biotechnology) price change was -19.47% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.17%. For the same industry, the average monthly price growth was -5.68%, and the average quarterly price growth was +64.91%.

Reported Earning Dates

CRBU is expected to report earnings on Mar 16, 2026.

Industries' Descriptions

@Biotechnology (-2.17% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRBU($170M) has a higher market cap than CING($23.1M). CRBU YTD gains are higher at: 14.465 vs. CING (-30.629). CING has higher annual earnings (EBITDA): -17.21M vs. CRBU (-150.76M). CRBU has more cash in the bank: 184M vs. CING (8.9M). CING has less debt than CRBU: CING (6.58M) vs CRBU (25.9M). CRBU has higher revenues than CING: CRBU (9.12M) vs CING (0).
CINGCRBUCING / CRBU
Capitalization23.1M170M14%
EBITDA-17.21M-150.76M11%
Gain YTD-30.62914.465-212%
P/E Ratio0.02N/A-
Revenue09.12M-
Total Cash8.9M184M5%
Total Debt6.58M25.9M25%
TECHNICAL ANALYSIS
Technical Analysis
CINGCRBU
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
85%
Momentum
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 8 days ago
81%
Bullish Trend 8 days ago
80%
Declines
ODDS (%)
Bearish Trend 22 days ago
90%
Bearish Trend 2 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 6 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
77%
View a ticker or compare two or three
Interact to see
Advertisement
CING
Daily Signal:
Gain/Loss:
CRBU
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HANNF0.570.02
+4.26%
Hannan Metals, Ltd.
ARRJF3.27N/A
N/A
Arjo AB
DCSX2.28N/A
N/A
Direct Communication Solutions, Inc.
SBFFF28.28N/A
N/A
SBM Offshore NV
TEVJF18.50N/A
N/A
Teva Pharmaceutical Industries Ltd.

CING and

Correlation & Price change

A.I.dvisor tells us that CING and ABCL have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CING and ABCL's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CING
1D Price
Change %
CING100%
+1.18%
ABCL - CING
32%
Poorly correlated
-1.23%
ZNTL - CING
30%
Poorly correlated
-2.21%
RXRX - CING
29%
Poorly correlated
-3.12%
BEIGF - CING
29%
Poorly correlated
N/A
CRBU - CING
29%
Poorly correlated
-2.67%
More